• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Eikon Therapeutics

‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M

January 6, 2022
Bit Bio Limited

This Startup Is Making—and Programming—Human Cells

December 20, 2021
Everly Health

EXCLUSIVE: The parent company of home-health testing brand Everlywell is buying Natalist, a reproductive health startup

October 21, 2021
Evonetix

Evonetix granted patent for DNA data storage and retrieval method

September 30, 2021
Alumis, Inc.

Esker Therapeutics snags former Principia CEO in hiring spree

September 23, 2021
Cue Health

With Cue Health IPO On Tap, Other Startups With COVID Tests Are Also Scaling

September 22, 2021
HealthVerity

HealthVerity partners with J&J’s Janssen to provide real-world data for clinical trial, R&D work

September 22, 2021
Cue Health

Covid Test Maker Cue Health Files for IPO After Revenue Gains

September 3, 2021
Pardes Biosciences

Startup Pardes Biosciences Joins Hunt for Covid-19 Pill

August 26, 2021
Quantum-Si

Proteomics May Be The Future Of Biotech, Quantum-Si Is A Potential Leader

July 20, 2021
Page 5 of 25« First«...34567...1020...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close